Management
Extensive Experience. Proven Execution.
Henry Wu
Education
Rutgers University, Ph.D. in Biostatistics
Tsinghua University, BS in Electrical Engineering and Industrial Engineering
Industry Experience
19 years of industry experience, worked at Pfizer and Roche
2003-2010 Founded a statistical consulting firm in the US
2010-2016 Head of the K&L data and statistics division
2013-2016 COO and CEO of Fountain Medical Development
Achievements
Led and completed more than 25 statistical and analysis projects in FDA/EMA NDA applications.
Yiren Dai
Education
MBA, Business Administration, Uninversity of Michigan
BS, Sport Physiology and Biochemistry, Beijing Sport University
Industry Experience
Experienced in strategic management, industrial operation, and system complianc
Experienced in systematic corporate developmnet, strategic market planning
China CEO of DJO Global, a leading medical device manufacturer of the world, fully responsible for China’s business including founding the team, and achieving outstandings
Managing Director, Highlight Capital, which focuses on early investment of innovative products and services for biohealth
Mutiple roles at Johnson & Johnson, Director of Corporate Strategic Account, Business department Head of Neurosurgery and Interventional Therapy
Product Manager, Nike China, laid a foundation of China’s business development
Crystal Xu
Education
Norman Bethune Health Science Center of Jilin University, Clinical Medicine, M.D.
Peking Union Medical College, Master of Medicine and Clinical Pharmacology
Industry Experience
More than 30 years’ experience in clinical medicine and New Drug Research and Development.
1983-1997，14-years clinical practice experience in the hospitals affiliated to Chinese Academy of Medical Sciences
1997-2012, worked in several international biopharmaceutical companies as the head of medical affair, clinical operations and regulatory affairs, such as Genzyme、 Hutchison MediPharma Global R & D、MDS.
2012-2019, worked in CANbridge Life Sciences as executive Director of Medical Affairs and the Head of Clinical development.
Achievements
Led more than 80 IND/NDA programs in China and Asia Pacific, the programs covering many fields: blood diseases, tumors, transplants, cardiovascular diseases, autoimmune diseases, kidney diseases, genetic diseases, rare diseases, etc.
Among them, 36 new drugs for innovative anti-cancer and autoimmune disease approved from FDA, EMA and NMPA.
Lijun Xiao
Education
Jiamusi Medical College, Bachelor of Pharmacy
Industry Experience
27 years of industry experience, 18 years of regulatory registration experience and 9 years of preclinical research and development experience
Deputy Director, Director and Senior Director of Fountain Medical Pharmaceuticals Registration Department
Successfully filed IND and NDA applications for dozens of chemical and biological products as well as imported drugs. Participated in early clinical development for dozens of innovative drugs as a strategic advisor.
Registered hundreds of pharmaceutical products
Successfully completed US-China dual registration for multiple products
Richard Zhang
Education
Shenyang Pharmaceutical University, Bachelor of Pharmaceutical Engineering
Industry Experience
VP of Pharmaron, currently responsible for Pharmaron and its subsidiaries’ clinical work, such as formulation of clinical trial strategies, clinical trial planning and execution, test drug supply chain management, quality management and etc.
Worked in several leading global and domestic pharmaceutical companies, engaged in team management and project management, and worked in foreign headquarters.
Managed and participated in nearly 50 clinical trial projects, involving different treatment areas, such as tumor, digestion, endocrine, rheumatism, reproductive health, mental, infection and etc.
Achievements
Served as the chairman and speaker of the DIA annual meeting branch venue many times, and also the member and speaker of the organizing committee at domestic academic conferences.
Served as deputy leader of the project management team in Shanghai Pharmaceutical Association’s Clinical Research Special Committee and special lecturer in Huashan Hospital of Fudan University.
Mandy Xu
Education
Peking University School of Medicine, Pharm.D
Industry Experience
11 years of pharmacokinetics research, regulatory experience and bioanalytical management experience, including ADME screening platform, IND DMPK filing, and regulatory bioanalysis to support GLP toxicology and clinical research
Vice President, DMPK and Regulatory Bioanalysis, Pharmaron
Head of Clinical Bioanalytical Testing Laboratory, Pharmaron, with extensive experience in the fields of biotransformation, ADME, and drug-drug interaction
Familiar with pre-clinical and clinical registration of innovative drugs with NMPA and FDA submissions
Yumei Peng
Education
Xi’an Jiaotong University, Master of Bioengineering, Genetic Statistics
Xi’an Jiaotong University, Bachelor of Bioengineering
Industry Experience
Over 10 years of biostatistics and programming experience.
Pharmaceutical Biostatistics Manager, Senior Manager and Director in MacroStat, Fountain Medical Development.
Responsible for statistics and programming of multiple Phase I to IV international and domestic projects (involving different therapeutic areas), 2 US NDA submissions and multiple Chinese NDA submissions.
Pei-Yun Chen
Education
North Carolina State University, Ph.D. in Biostatistics
National Chengchi University, MBA in Statistics
National Taiwan University, Bachelor of Mathematics
Industry Experience
Over 18 years of experience in biostatistics industry.
Senior Statistician, Deputy Director of Statistics, Director and Senior Director in Merck, FMD K&L.
Participated in multiple FDA NDA submissions across various therapeutic areas.